HispanicBusiness

"I selected Quture from many other opportunities because I am convinced that this company, its products, strategies, and its vision have the best opportunity to dominate the global market and to achieve my professional goals for transforming health and health care," said Rudisill. "With the elections over and knowing that the Affordable Care Act will stand, the opportunities for Quture are even greater. I firmly believe that the key to improving healthcare, and subsequently lowering costs, is through the careful application of technology. Improving clinical quality is about focusing on processes and looking at how they could be improved and streamlined. We have to be forward thinking and the only way to have a real impact is through technology that will take us into the future. We need to evolve from healthcare silo based processes, to a foundation of an Outcomes Prospective Continuum with decisions supported from Knowledge rather than retrospective Data or Concurrent Information."

ABOUT QUTURE INTERNATIONAL, INC. (www.quture.com)
Quture International, Inc. (QUTR) is the proven and experienced performance and outcomes analytics company in the United States. The vision of Quture is to connect all constituents in the global health and health care community to clinically and financially focused and sound data transformed through analytics to knowledge that empowers data-driven decisions for results-driven success. As a "Breakthrough" Application Partner of InterSystems Corporation, Quture's technology for capturing, integrating and aggregating data on the InterSystems Enterprise platform is unequalled. The Company's unique product QualOptima develops a second generation CLINICAL database implementing Quture's core competence of clinical content with evidence-based metrics developed for more than 35 years. QualOptima empowers clinical performance enhancement to achieve optimal patient outcomes. Quture's brand is centered on the value proposition of trust, transparency and independence. As the free enterprise solution to improving health and healthcare while reducing costs, Quture is positioned to become the leading clinical knowledge company in the world. Quture International is a Nevada corporation trading under the symbol QUTR.

This release contains forward-looking statements, including, without limitation, statements concerning our business and possible or assumed future results of operations. Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons including: our ability to continue as a going concern, adverse economic changes affecting markets we serve; competition in our markets and industry segments; our timing and the profitability of entering new markets; greater than expected costs, customer acceptance of our products or difficulties related to our integration of the businesses we may acquire; and other risks and uncertainties as may be detailed from time to time in our public announcements and SEC filings. Although we believe the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and our future results, levels of activity, performance or achievements may not meet these expectations. We do not intend to update any of the forward-looking statements after the date of this document to conform these statements to actual results or to changes in our expectations, except as required by law. There is no assurance that a definitive agreement will be completed.



For Further Information Contact:
Constellation Asset Advisors, Inc.
Jens Dalsgaard
President
+1 (415) 524-8500

Contact:
Mele Telitz
Director of Communications
(855) 740-QUTR (7878)
mele@quture.com